EWA LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Buy
3,938
+798
+25% +$105K 0.09% 134
2026
Q1
$438K Buy
3,140
+320
+11% +$44.8K 0.1% 116
2025
Q4
$346K Sell
2,820
-21
-0.7% -$2.55K 0.08% 134
2025
Q3
$315K Buy
2,841
+90
+3% +$10.2K 0.09% 122
2025
Q2
$305K Sell
2,751
-423
-13% -$45K 0.1% 113
2025
Q1
$356K Buy
+3,174
New +$328K 0.13% 79

Other funds holding GILD

EWA LLC's GILD Position: Q2 2026 in Review

EWA LLC increased its Gilead Sciences (GILD) stake by 25% in Q2 2026, buying an estimated $105K and bringing the position to 3,938 shares worth $498K. The position accounts for 0.09% of the portfolio, ranked #134.

EWA LLC first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • EWA LLC held 3,938 shares of Gilead Sciences worth $498K as of Q2 2026.
  • EWA LLC bought 798 Gilead Sciences shares in Q2 2026, an estimated $105K.
  • Gilead Sciences made up 0.09% of EWA LLC's portfolio in Q2 2026, its #134 holding.
  • EWA LLC first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.